IDEAS home Printed from https://ideas.repec.org/a/cup/buetqu/v15y2005i04p577-594_00.html
   My bibliography  Save this article

The Corporate Social Responsibility of the Pharmaceutical Industry: Idealism without Illusion and Realism without Resignation

Author

Listed:
  • Leisinger, Klaus M.

Abstract

In recent years society has come to expect more from the “socially-responsible” company and the global HIV/AIDS pandemic in particular has resulted in some critics saying that the “Big Pharma” companies have not been living up to their social responsibilities. Corporate social responsibility can be understood as the socio-economic product of the organizational division of labor in complex modern society. Global poverty and poor health conditions are in the main the responsibilities of the world’s national governments and international governmental organizations, which possess society’s mandate and appropriate organizational capabilities. Private enterprises have neither the societal mandate nor the organizational capabilities to feed the poor or provide health care to the sick in their home countries or in the developing world. Nevertheless, private enterprises do have responsibilities to society that can be categorized as what they must do, what they ought do, and what they can do.

Suggested Citation

  • Leisinger, Klaus M., 2005. "The Corporate Social Responsibility of the Pharmaceutical Industry: Idealism without Illusion and Realism without Resignation," Business Ethics Quarterly, Cambridge University Press, vol. 15(4), pages 577-594, October.
  • Handle: RePEc:cup:buetqu:v:15:y:2005:i:04:p:577-594_00
    as

    Download full text from publisher

    File URL: https://www.cambridge.org/core/product/identifier/S1052150X00007855/type/journal_article
    File Function: link to article abstract page
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Włodzimierz Sroka & Richard Szántó, 2018. "Corporate Social Responsibility and Business Ethics in Controversial Sectors: Analysis of Research Results," Journal of Entrepreneurship, Management and Innovation, Fundacja Upowszechniająca Wiedzę i Naukę "Cognitione", vol. 14(3), pages 111-126.
    2. Olga Bruyaka & Hanko Zeitzmann & Isabelle Chalamon & Richard Wokutch & Pooja Thakur, 2013. "Strategic Corporate Social Responsibility and Orphan Drug Development: Insights from the US and the EU Biopharmaceutical Industry," Journal of Business Ethics, Springer, vol. 117(1), pages 45-65, September.
    3. Davide Fiaschi & Elisa Giuliani, 2011. "The impact of business on society: exploring CRS adoption and alleged human rights abuses by large corporations," LEM Papers Series 2011/13, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
    4. Matthew Lee & Jillian Kohler, 2010. "Benchmarking and Transparency: Incentives for the Pharmaceutical Industry’s Corporate Social Responsibility," Journal of Business Ethics, Springer, vol. 95(4), pages 641-658, September.
    5. Ivan Montiel & Junghoon Park & Bryan W. Husted & Andres Velez-Calle, 2022. "Tracing the connections between international business and communicable diseases," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 53(8), pages 1785-1804, October.
    6. Elisa Giuliani & Chiara Macchi, 2014. "Multinational corporations’ economic and human rights impacts on developing countries: a review and research agenda," Cambridge Journal of Economics, Cambridge Political Economy Society, vol. 38(2), pages 479-517.
    7. Elisa Giuliani, 2016. "Human Rights and Corporate Social Responsibility in Developing Countries’ Industrial Clusters," Journal of Business Ethics, Springer, vol. 133(1), pages 39-54, January.
    8. Suchanek Andreas & Lin-Hi Nick, 2007. "Corporate Responsibility in der forschenden Arzneimittelindustrie / Corporate Responsibility in the Research-Based Pharmaceutical Industry," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), De Gruyter, vol. 227(5-6), pages 547-562, October.
    9. Sui-Hua Yu & Wan-Chen Liang, 2020. "Exploring the Determinants of Strategic Corporate Social Responsibility: An Empirical Examination," Sustainability, MDPI, vol. 12(6), pages 1-16, March.
    10. Thomas Donaldson, 2023. "Value creation and CSR," Journal of Business Economics, Springer, vol. 93(6), pages 1255-1275, August.
    11. Marialuisa Saviano & Sergio Barile & Francesco Caputo & Mattia Lettieri & Stefania Zanda, 2019. "From Rare to Neglected Diseases: A Sustainable and Inclusive Healthcare Perspective for Reframing the Orphan Drugs Issue," Sustainability, MDPI, vol. 11(5), pages 1-21, March.
    12. James Huebner, 2014. "Moral Psychology and the Intuition that Pharmaceutical Companies Have a ‘Special’ Obligation to Society," Journal of Business Ethics, Springer, vol. 122(3), pages 501-510, July.
    13. Pepijn Pol & Frank Bakker, 2010. "Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?," Journal of Business Ethics, Springer, vol. 94(2), pages 211-224, June.
    14. Som Sekhar Bhattacharyya & Sumi Jha & Dinesh Sharma, 2020. "Development of a Scale on Individual Perspectives on Corporate Social Responsibility Constructs: Based on Microfoundation Theory," Vision, , vol. 24(1), pages 47-59, March.
    15. Bernhard Swoboda & Cathrin Huber & Tassilo Schuster & Johannes Hirschmann, 2017. "Corporate Reputation Effects Across Nations: The Impact of Country Distances and Firm-Specific Resources," Management International Review, Springer, vol. 57(5), pages 717-748, October.
    16. Lixin Shen & Kannan Govindan & Madan Shankar, 2015. "Evaluation of Barriers of Corporate Social Responsibility Using an Analytical Hierarchy Process under a Fuzzy Environment—A Textile Case," Sustainability, MDPI, vol. 7(3), pages 1-22, March.
    17. Helen LaVan & Lori S. Cook & Ivana Zilic, 2021. "An analysis of the ethical frameworks and financial outcomes of corporate social responsibility and business press reporting of US pharmaceutical companies," International Journal of Business Governance and Ethics, Inderscience Enterprises Ltd, vol. 15(3), pages 326-355.
    18. Milan Dzupina & Zuzana Dzupinova, 2019. "Dimensions Of Csr In Online Communication Of Pharmaceutical Companies: A Comparative Study," International Journal of Entrepreneurial Knowledge, Center for International Scientific Research of VSO and VSPP, vol. 7(2), pages 41-52, December.
    19. Hans-Ulrich Küpper & Philipp Schreck, 2008. "Unternehmensethik in Praxis, Forschung und Lehre–Status quo und Perspektiven im deutschsprachigen Raum," Schmalenbach Journal of Business Research, Springer, vol. 60(58), pages 72-92, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:cup:buetqu:v:15:y:2005:i:04:p:577-594_00. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Kirk Stebbing (email available below). General contact details of provider: https://www.cambridge.org/beq .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.